Saturday, October 2, 2021

Ivermectin for COVID-19: real-time meta analysis of 65 studies

 https://ivmmeta.com/?fbclid=IwAR25Du6lrIXJoAtB1mjEXIvE-NNup_zuD5QlAKKzux3UtPuEuZiqzux7B-o

No comments: